News
Capital Market on MSN20m
Nectar Life slumps on selling core pharma business to Ceph Lifesciences for Rs 1,270 CrThe deal, executed on a slump sale basis, includes the manufacture, distribution, and marketing of APIs (active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback